Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.0551 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.022 | 0.2199 | 0.2123 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.022 | 0.2199 | 0.2123 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0409 | 0.6666 | 0.6633 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0409 | 0.6666 | 0.6633 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0551 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.022 | 0.2199 | 0.2123 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0142 | 0.0363 | 0.0269 |
Toxoplasma gondii | fructose-bisphospatase II | 0.0551 | 1 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.0551 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0218 | 0.2144 | 0.2067 |
Schistosoma mansoni | tyrosine kinase | 0.0409 | 0.6666 | 0.6633 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0131 | 0.0097 | 0.0097 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.0551 | 1 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.022 | 0.2199 | 0.2123 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.0551 | 1 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.022 | 0.2199 | 0.2199 |
Leishmania major | 0.0551 | 1 | 0.5 | |
Brugia malayi | Cytochrome P450 family protein | 0.0142 | 0.0363 | 0.0269 |
Echinococcus multilocularis | insulin receptor | 0.0131 | 0.0097 | 0.0097 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.0551 | 1 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0409 | 0.6666 | 0.6666 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0409 | 0.6666 | 0.6633 |
Schistosoma mansoni | tyrosine kinase | 0.0218 | 0.2144 | 0.2067 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.0551 | 1 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.0218 | 0.2144 | 0.2067 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.